Welcome to ChromoCure
About ChromoCure

ChromoCure develops proprietary technologies based on the chromosomal theory of cancer.  The Company has proprietary technology, designs, protocols, and algorithms for cancer detection. The Company’s technology has been proven to have an effective accuracy of 100% for all cancers at all stages with zero false positives or false negatives and an effective 100% specificity. The Company believes its technology will become the international gold standard for cancer detection, therapy and cure research.

Read more...
 
Project Boveri: Find the Cure

Supported by recent third party medical findings, the Company is calling for a stepped up collaborative approach through its Project Boveri: Find the Cure initiative; and is inviting industry, institutions, medical research centers and government to partner in this initiative.

Note that the Diagnostic Laboratory Partnership Outreach Program for pathologists and diagnostic labs will be incorporated into Project Boveri in order to broaden awareness of the company’s technology.

Read more...
 
Superior Tech Earns ChromoCure More Industry Support

ChromoCure gains more industry support as its technology shown superior to ‘biomarkers’: Biomarker Assays Diagnostics “not produced hoped-for results”

 

RENO, NV –March 4, 2009 - ChromoCure, Inc. (OTCPK: KKUR) – ChromoCure’s role in Cancer Detection and Research received more support from a report of the Cambridge Healthtech Institute’s (CHI) “Biomarker Assay Development” conference held in late January in San Diego. Read more...

 
Learn About Cancer

Normal human cells have 23 different chromosomes that come in pairs. They yield a total of 46 chromosomes. Such cells are said to be “diploid.” Cells found in solid tumors, on the other hand, typically have between 60 to 90 chromosomes (1). Their ploidy is “not good,” in other words, and the Greek version of that is “aneuploid.” It is a word that you will have a hard time finding in the cancer textbooks.

Read more...
 
ChromosomalScanner Series 200

The system employs the most accurate method for detecting cancer in any tissue sample because it provides an automated method for detecting the presence or absence of advanced chromosomal imbalance. Research has conclusively, and irrefutably demonstrated aneuploidy as a more accurate predictor of cancer than cytological/histological analysis or genetic marker-based diagnostics that are the only other methods in existence today.

Read more...
 
Research Library

Aneuploidy vs Gene mutation theories of Cancer

The origin and nature of cancer has been one of the great enigmas since the time of the Egyptians and Greeks. The central paradox is that tumors are us and yet not us. The hundreds of different types of cancer are distinguishable in their details yet they all display the global characteristics that readily identify them as cancer: new growth, metastasis, genetic instability, invasiveness, multi-drug-resistance, and the exceedingly long times of up to decades from carcinogen exposure to the appearance of cancer.

Read more...